Kenyan Health Patient Information Leaflet
Nitroimidazole antimicrobial / antiprotozoal
Therapeutic use is agent- and indication-specific within the class (Nitroimidazole antimicrobial / antiprotozoal). Use according to culture results, national guidelines (Kenya STG/EML where applicable) and the current product SmPC. Amoebiasis.
Dosing is indication-, age-, weight- and organ-function-specific for this INN. Do not use class averages for high-risk patients. Confirm the exact regimen in the current SmPC and Kenya Standard Treatment Guidelines. Typical professional workflow: (1) confirm indication, (2) check renal/hepatic function, (3) screen interactions/allergies, (4) select dose/route/duration, (5) define monitoring.
[From component Metronidazole] GI discomfort, anorexia, metallic taste, dry mouth, headache, skin rash, vertigo, depression, insomnia, drowsiness, urethral discomfort, darkened urine, transient fall in BP, temporary leucopenia, bone marrow depression, transient epileptic seizure, furred tongue.
Store as labelled. Keep out of reach of children.